| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2011 | US20110217313 Treatment of orthopedic conditions |
| 09/08/2011 | US20110217311 Cycloalkyl containing thienopyrimidines for pharmaceutical compositions |
| 09/08/2011 | US20110217309 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors |
| 09/08/2011 | US20110217301 Methods for treating or screening for compounds for the treatment of sepsis |
| 09/08/2011 | US20110217300 Quinazolinone Compounds and Methods of Use Thereof |
| 09/08/2011 | US20110217299 Targeting pax2 for the treatment of breast cancer |
| 09/08/2011 | US20110217297 Methods for classifying and treating breast cancers |
| 09/08/2011 | US20110217296 Method for selecting patients for treatment with an egfr inhibitor |
| 09/08/2011 | US20110217295 Treatment of lupus arthritis using laquinimod |
| 09/08/2011 | US20110217293 Uses of morelloflavone |
| 09/08/2011 | US20110217290 Treatment and/or prevention of peanut induced anaphylaxis |
| 09/08/2011 | US20110217289 Melt-Coated Dosage Forms |
| 09/08/2011 | US20110217286 Stabilized anthocyanin compositions |
| 09/08/2011 | US20110217281 Methods for diagnosis and prognosis of cancer |
| 09/08/2011 | US20110217280 Methods for treating neuropsychiatric conditions |
| 09/08/2011 | US20110217279 Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase c-delta and erk related conditions |
| 09/08/2011 | US20110217278 Medication and Treatment for Disease |
| 09/08/2011 | US20110217277 Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus |
| 09/08/2011 | US20110217276 Compositions for the prevention and treatment of primary headache and migraine |
| 09/08/2011 | US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof |
| 09/08/2011 | US20110217265 Screening for Inhibitors of HCV Amphipathic Helix (AH) Function |
| 09/08/2011 | US20110217262 Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability |
| 09/08/2011 | US20110217261 Combination pharmaceutical agents as inhibitors of hcv replication |
| 09/08/2011 | US20110217259 IL-16 as a target for diagnosis and therapy of hematological malignancies and solid tumors |
| 09/08/2011 | US20110217258 Combined Use of Bendamustine, Doxorubicin and Bortezomib for the Treatment of Multiple Myeloma |
| 09/08/2011 | US20110217252 Compound useful for treating cellulite |
| 09/08/2011 | US20110217251 Therapeutic compositions comprising polyhydroxyltate fatty alcohol derivatives and uses thereof |
| 09/08/2011 | US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds |
| 09/08/2011 | US20110217248 Topical Composition |
| 09/08/2011 | US20110217247 Compositions and methods for protection of skin against thermal insult |
| 09/08/2011 | US20110217244 Compositions and methods for enhancing immune response |
| 09/08/2011 | US20110217243 Pharmaceutical identification |
| 09/08/2011 | US20110217242 Phenol with color |
| 09/08/2011 | US20110217239 System and method of evaluating a protein of interest on tumor growth inhibition while following the tumor in vivo or in vitro |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/08/2011 | DE102010010430A1 Filler material, useful for filling an ophthalmic implant, preferably self-accommodative lenses, comprises free-flowing silicone oils having a predetermined refractive index |
| 09/08/2011 | DE102010010360A1 Formulierungen von Taurolidin und Verfahren zu seiner Herstellung Formulations of taurolidine and process for its preparation |
| 09/08/2011 | DE102009046115A1 Substituierte 3-Phenylpropansäuren und ihre Verwendung Substituted 3-Phenylpropansäuren and their use |
| 09/07/2011 | EP2363493A1 Novel insertion sites in pox vectors |
| 09/07/2011 | EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 09/07/2011 | EP2363482A1 Compounds and methods for modulating gene expression |
| 09/07/2011 | EP2363481A1 Compounds and methods for modulating gene expression |
| 09/07/2011 | EP2363480A2 Modulation of glucocorticoid receptor expression |
| 09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
| 09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/07/2011 | EP2363467A1 Method for inhibiting function of micro-rna |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 09/07/2011 | EP2363400A2 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same |
| 09/07/2011 | EP2363399A1 Labelled analogues of halobenzamides as radiopharmaceuticals |
| 09/07/2011 | EP2363397A1 Novel useful therapeutic agent for lower urinary tract symptom |
| 09/07/2011 | EP2363396A1 Thiophene derivatives as antiviral agents for flavivirus infection |
| 09/07/2011 | EP2363395A2 Process for preparation of celecoxib crystalline form |
| 09/07/2011 | EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders |
| 09/07/2011 | EP2363393A1 Compounds and compositions as hedgehog pathway modulators |
| 09/07/2011 | EP2363390A1 Derived lactam from d3 vitamin |
| 09/07/2011 | EP2363156A2 Method of fabricating biodegradable medical devices with enhanced mechanical strength and pharmacological functions |
| 09/07/2011 | EP2363152A1 Cardiac arrhythmia treatment methods |
| 09/07/2011 | EP2363150A1 Compositions and methods for enhancing corticosteroid delivery |
| 09/07/2011 | EP2363148A1 Method for selectively controlling function of helper t cell |
| 09/07/2011 | EP2363147A1 Composition for local anesthesia |
| 09/07/2011 | EP2363142A1 Elastase for opening obstructed biological conduits |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2363134A1 Compositions and methods for inhibiting expression of factor V Leiden mutant gene |
| 09/07/2011 | EP2363133A1 Composition comprising DNA fragments and medical and cosmetic uses thereof |
| 09/07/2011 | EP2363132A1 The use of sophoricoside in preparing medicaments |
| 09/07/2011 | EP2363131A1 Famciclovir For The Treatment Of Recurrent Herpes Labialis Using A One-Day Treatment |
| 09/07/2011 | EP2363130A1 Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 09/07/2011 | EP2363129A1 Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases |
| 09/07/2011 | EP2363128A2 Indole modulators of ATP-binding cassette transporters |
| 09/07/2011 | EP2363127A1 PPAR Modulators |
| 09/07/2011 | EP2363126A1 Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| 09/07/2011 | EP2363125A1 Preparation for improving the sensitivity action of receptors |
| 09/07/2011 | EP2363124A1 Pharmaceutical compositions comprising droxidopa |
| 09/07/2011 | EP2363123A1 Pharmaceutical compositions comprising droxidopa |
| 09/07/2011 | EP2363122A1 Clonidine to treat pain locally |
| 09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
| 09/07/2011 | EP2363120A1 Combinations of dimebolin and memantine |
| 09/07/2011 | EP2363119A1 New pharmaceutical composition suitable for treating persons affected by neurodegenerative or neurovascular diseases |
| 09/07/2011 | EP2363118A1 Gum resin as a carrier for topical application of pharmacologically active agents |
| 09/07/2011 | EP2363114A1 Sustained release of antiinfectives |
| 09/07/2011 | EP2363111A1 Stable pharmaceutical composition comprising bisphosphonate |
| 09/07/2011 | EP2363104A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/07/2011 | EP2362909A2 Mammalian genes involved in infection |
| 09/07/2011 | EP2362908A1 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/07/2011 | EP2362876A1 Thienotriazolodiazepine derivatives active on apo a |
| 09/07/2011 | EP2362873A2 New crystal form of sunitinib malate |
| 09/07/2011 | EP2362872A2 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors |
| 09/07/2011 | EP2362870A2 Novel processes and pure polymorphs |
| 09/07/2011 | EP2362869A2 Polymorphs |
| 09/07/2011 | EP2362865A2 Deuterated 2-propylpentanoic acid compounds |
| 09/07/2011 | EP2362778A2 Compositions comprising vitamins |
| 09/07/2011 | EP2362775A1 Chemical compounds |
| 09/07/2011 | EP2362774A1 Anthelmintic compositions |
| 09/07/2011 | EP2362773A1 Methods for inducing programmed cell death |
| 09/07/2011 | EP2362772A1 Pharmaceutical association lipoic acid and hydroxycitric acid as active ingredients |
| 09/07/2011 | EP2362771A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease |
| 09/07/2011 | EP2362770A2 Compositions and methods for treating or preventing radiation injury |
| 09/07/2011 | EP2362768A1 Extended release oral acetaminophen/tramadol dosage form |
| 09/07/2011 | EP2362766A2 Pharmaceutical aerosol composition |